MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

RATIONALE AND OBJECTIVES Angiogenesis and proliferation activity are important indicators of tumor behavior in human gliomas. The authors studied how tumor enhancement in MR imaging and intratumoral vascular density were correlated with cell proliferation in cerebral gliomas. METHODS The authors studied retrospectively 62 cerebral gliomas. Patients were examined before surgery with contrast-enhanced MR imaging. Microvessel density and the cell proliferation rate of tumor specimens were measured immunohistochemically using factor VIII and MIB-1 antibodies. Contrast enhancement of the tumors was evaluated by two radiologists. RESULTS Contrast enhancement was observed in 45 tumors and was correlated with histologic cell proliferation (P = 0.0007) and microvessel density (P = 0.01). There was also a correlation between tumor vascular density and the cell proliferation rate (r = 0.51, P < 0.0001). Histologic tumor grade was associated with vascular density (P = 0.001). CONCLUSIONS Lesion enhancement on preoperative contrast-enhanced MR imaging correlates with vascularity and proliferation activity of gliomas. The additional correlation between tumor vascularity and proliferation suggests that intratumoral microvessel density could be useful in estimating tumor proliferation.

[1]  A. Lee,et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.

[2]  M. Wendland,et al.  Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade. , 1998, Academic radiology.

[3]  P. Black,et al.  Microvessel density is a prognostic indicator for patients with astroglial brain tumors , 1996, Cancer.

[4]  D. Thomas,et al.  Cell proliferation in serial biopsies through human malignant brain tumours: measurement using Ki67 antibody labelling. , 1991, British journal of neurosurgery.

[5]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[6]  C R Bird,et al.  Gliomas: classification with MR imaging. , 1990, Radiology.

[7]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[8]  C. Claussen,et al.  Brain tumors: MR imaging with gadolinium-DTPA. , 1985, Radiology.

[9]  M. Brant-Zawadzki.  Pitfalls of contrast‐enhanced imaging in the nervous system , 1991, Magnetic resonance in medicine.

[10]  J. Ehrhardt,et al.  MR evaluation of CNS tumors: dose comparison study with gadopentetate dimeglumine and gadoteridol. , 1991, Radiology.

[11]  S. Coons,et al.  Regional Heterogeneity in the Proliferative Activity of Human Gliomas as Measured by the Ki‐67 Labeling Index , 1993, Journal of neuropathology and experimental neurology.

[12]  G. Fuller,et al.  The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. , 1998, Surgical neurology.

[13]  Susan M. Chang,et al.  Age and the risk of anaplasia in magnetic resonance‐nonenhancing supratentorial cerebral tumors , 1997, Cancer.

[14]  J. Hesselink,et al.  Clinical experience with routine Gd-DTPA administration for MR imaging of the brain. , 1990, Journal of computer assisted tomography.

[15]  M. Prados,et al.  Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling , 1993, International journal of cancer.

[16]  R. Paola,et al.  Correlation Between Contrast Enhancement in Dynamic Magnetic Resonance Imaging of the Breast and Tumor Angiogenesis , 1994, Investigative radiology.

[17]  M. Koike,et al.  Correlation between bromodeoxyuridine‐labeling indices and patient prognosis in cerebral astrocytic tumors of adults , 1991, Cancer.

[18]  A. Chiò,et al.  Prognostic value of histologic factors in adult cerebral astrocytoma , 1988, Cancer.

[19]  C. Angeletti,et al.  Relation of neovascularisation to metastasis of non-small-cell lung cancer , 1992, The Lancet.

[20]  J W Belliveau,et al.  Ultrafast imaging of brain tumors , 1993, Topics in magnetic resonance imaging : TMRI.

[21]  D A Bluemke,et al.  Tumor angiogenesis: tutorial on implications for imaging. , 1997, Radiology.

[22]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[23]  G Brix,et al.  Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. , 1997, Cancer research.

[24]  D. Ross,et al.  A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters. , 1997, Journal of neuropathology and experimental neurology.

[25]  M. Hamou,et al.  Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. , 1988, Neurosurgery.

[26]  G. Bydder,et al.  INTRAVENOUS CHELATED GADOLINIUM AS A CONTRAST AGENT IN NMR IMAGING OF CEREBRAL TUMOURS , 1984, The Lancet.

[27]  Bruce R. Rosen,et al.  Echo-Planar MR Cerebral Blood Volume Mapping of Gliomas , 1995 .

[28]  D. Norman,et al.  Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions. , 1986, AJR. American journal of roentgenology.

[29]  R. Coombs,et al.  Modification of human red cells by virus action; agglutination by incomplete Rh antibody. , 1947, Lancet.

[30]  Sage Mr.  Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. , 1982, AJR. American journal of roentgenology.

[31]  G. Butti,et al.  Ploidy and proliferative activity of human brain tumors. A flow cytofluorometric study. , 1987, Oncology.